Results 91 to 100 of about 1,288 (185)

Enhancing Flucytosine Anticandidal Activity Using PEGylated Squalene Nanocarrier

open access: yesChemMedChem, Volume 20, Issue 1, January 2, 2025.
Our study focused on improving the effectiveness of the antifungal drug 5‐fluorocytosine (5FC) by loading it in micellar structures formed by PEGylated squalene copolymer. The obtained results for 5FC‐loaded micelles showed in vitro prolonged release under physiological conditions and improved in vitro antifungal activity without cytotoxicity for ...
Bogdan‐Florin Craciun   +3 more
wiley   +1 more source

Kangbainian Lotion Ameliorates Vulvovaginal Candidiasis in Mice by Inhibiting the Growth of Fluconazole-Resistant Candida albicans and the Dectin-1 Signaling Pathway Activation

open access: yesFrontiers in Pharmacology, 2022
Vulvovaginal candidiasis (VVC) is an infectious disease caused by Candida species, which affects millions of women worldwide every year. The resistance to available antifungal drugs for clinical treatment is a growing problem. The treatment of refractory
Zewei Chen   +8 more
doaj   +1 more source

Hybrid Nanoparticles Dual‐Loaded With Curcumin and Benzydamine Hydrochloride for the Treatment of Vulvovaginal Candidiasis: From Development to Biological Application In Vitro and In Vivo

open access: yesAdvanced Therapeutics, Volume 8, Issue 1, January 2025.
This study offers new possibilities for the development of silica‐based hybrid nanoparticles by microfluidics and highlights the potential combination of curcumin and benzydamine hydrochloride for the treatment of vulvovaginal candidiasis. This disease is a public health challenge due to its reports of high incidence, recurrences and resistance to ...
Gabriela C. Carvalho   +15 more
wiley   +1 more source

Exploring the Depths of Cryptic Aspergillosis: Species Variability, Clinical Spectrum, Diagnostic Quandaries and Therapeutic Options [PDF]

open access: yesJournal of Clinical and Diagnostic Research
Cryptic aspergillosis, characterised by infections caused by non classical Aspergillus species, presents unique challenges in clinical management due to species variability, diverse clinical manifestations, diagnostic complexities, and limited treatment ...
Almas Fathima Upaisal   +1 more
doaj   +1 more source

Antifungal Therapy and Probiotics in Women's Health - A Comprehensive Review [PDF]

open access: yes
Candida-induced infections affect millions of women around the world. Therefore, the purpose of this review is to provide a comprehensive analysis of the role of antifungal therapy and probiotics in managing one such infection, vulvovaginal candidiasis ...
Amangeldi, Alma   +14 more
core   +2 more sources

Lactams Exhibit Potent Antifungal Activity Against Monospecies and Multispecies Interkingdom Biofilms on a Novel Hydrogel Skin Model

open access: yesAPMIS, Volume 133, Issue 1, January 2025.
ABSTRACT Infections of intact and damaged skin barriers and keratin are frequently associated with complex biofilm communities containing bacteria and fungi, yet there are limited options for successful management. This study intended to focus on the utility of some novel proprietary lactam molecules, quorum sensing (QS)–derived halogenated furanones ...
Hafsa Abduljalil   +8 more
wiley   +1 more source

Multidrug resistance mechanisms and therapeutic strategies in Candida auris [PDF]

open access: yes
In recent years, Candida auris has emerged as a formidable global health threat due to its multidrug resistance, high transmissibility in healthcare settings, and diagnostic challenges. Unlike most Candida species, C. auris can colonize the skin, persist
Alkaabi, Sara
core   +2 more sources

The Significance of Mono‐ and Dual‐Effective Agents in the Development of New Antifungal Strategies

open access: yesChemical Biology &Drug Design, Volume 105, Issue 1, January 2025.
The future of treating challenging fungal infections lies in novel therapies targeting new antifungal targets, overcoming resistance mechanisms, and exploring innovative dual inhibitors. ABSTRACT Invasive fungal infections (IFIs) pose significant challenges in clinical settings, particularly due to their high morbidity and mortality rates.
Cengiz Zobi, Oztekin Algul
wiley   +1 more source

Research progress of hydrogels in the prevention of pelvic inflammatory disease

open access: yesMedComm – Biomaterials and Applications, Volume 3, Issue 4, December 2024.
This image summarizes pathogens and therapeutic interventions for pelvic inflammatory disease. We summarize the intrinsic properties of hydrogels and the application methods used in vagina and urinary tract infections. Abstract Pelvic inflammatory disease (PID) is a critical global health concern with the potential to lead to adverse outcomes ...
Yile Xiao   +11 more
wiley   +1 more source

In Vitro Activity of Ibrexafungerp, a Novel Glucan Synthase Inhibitor against Candida glabrata Isolates with FKS Mutations [PDF]

open access: yesAntimicrobial Agents and Chemotherapy, 2019
Ibrexafungerp is a first-in-class glucan synthase inhibitor. In vitro activity was determined for 89 Candida glabrata isolates with molecularly identified FKS1 or FKS2 mutations conferring resistance to the echinocandins.
Natalie S, Nunnally   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy